Legend Biotech (LEGN)
(Delayed Data from NSDQ)
$44.42 USD
-0.75 (-1.66%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $44.41 -0.01 (-0.02%) 6:22 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Legend Biotech Corporation Sponsored ADR [LEGN]
Reports for Purchase
Showing records 1 - 20 ( 30 total )
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
Key Takeaways From ODAC 11-0 Vote Favoring CARVYKTI in 2L; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
OS Is Clearer than Kaplan-Meier Curves Project; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
ODAC Briefing Docs Today; ODAC Friday; 2023 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
CHMP Opinion Further Validates Path to CARVYKTI 2L Approval; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
First TIL Approval Validates Cell Therapy Class
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
New York Investor Dinner Event Key Takeaways; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
AdCom Opinion Next Month: Positive CARVYKTI Implications; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
2024 Top Picks: Seeing Important Turnaround Year While Watching the Macro
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
2024 Top Picks: Seeing Important Turnaround Year While Watching the Macro
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
ABECMA Approval Supported in 2L MM-Positive For CARVYKTI; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
CARVYKTI 2024 Growth; We Still Expect 2L+ MM Approval; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
DLL-3 Deal Closed; CARVYKTI Label Addendum Details; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
CARVYKTI FDA Label Safety Update Does Not Affect Our Thesis; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
FDA CAR-T Class Investigation Unlikely to Impact Carvykti; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for LEGN 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
Carvykti Growth to Accelerate Next Year; 3Q23 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
DLL-3 Deal With Novartis Validates LB2102 and Pipeline; Raising PT to $87
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
We See Little Threat to Carvykti from CART-ddBCMA; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
Another Impressive Carvykti Sales Growth Quarter; Raising PT to $86
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M
Company: Legend Biotech Corporation Sponsored ADR
Industry: Medical - Biomedical and Genetics
New Myeloma Drugs Do Not Impact CARVYKTI, In Our View; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: KAPOOR M